11:00 CET

Webcast positive OCEAN topline results

Oncopeptides presents positive topline results from the phase 3 OCEAN and hosts a webcast today, May 25, 2021, at 11:00 (CET). 

Webcast for investors, analysts, and the media
The webcast will include presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas Bakker, and CFO Anders Martin-Löf.

The webcast will be streamed via the web link
https://tv.streamfabriken.com/oncopeptides-press-conference-2-2021 

Participant dial-in number
Sweden: +46 856642651
United Kingdom: +44 3333000804
United States: +1 6319131422

Participant Pin code
76430921# 

Link to the presentation

Link to the press release

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-